PFHxS Causes Developmental Hypothyroxinemia Without Affecting Behavioral Tests in Rat Offspring

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

132 Downloads (Pure)

Abstract

Introduction
Thyroid hormones (TH) are critical for mammalian brain development. In humans, low maternal serum thyroxine (T4) levels are associated with neurological deficiencies and cognitive impairment. Perfluorohexane sulfonate (PFHxS) is a widespread environmental contaminant found in human serum, tissues and milk. We have shown that PFHxS decrease serum thyroxine in pregnant rat dams and their offspring. Here, we further investigate effects on the thyroid system, neurodevelopment, and combination effects of PFHxS and a mixture of environmentally relevant endocrine disruptors.
Methods
Perfluorohexane sulfonate (PFHxS, 0, 0.05, 5 or 25 mg/kg/day with and without EDmix, a mixture of 12 endocrine disruptors e.g. phthalates, pesticides, UV-filters, Bisphenol A and butyl paraben) was administered (p.o.) to Wistar rat dams (n = 16-20/dose group) from gestation day (GD) 7 through postnatal day (PD) 22. Offspring were assessed in activity boxes and the radial arm maze.
Results/discussion
PFHxS not only decreased serum T4 levels in dams and offspring but in the high dose also reduced T3 to 84% of controls in both dams (PD 22) and pups (PD 16). The hypothalamic-pituitary-thyroid (HPT) axis was not activated based on lack of effect on serum TSH, thyroid gland histology, weight and thyroid gene expression levels. Developmental hypothyroxinemia did not appear to increase physical activity levels in young and adult offspring. However, the expected sex difference was absent on PD 115 in low dose PFHxS (0.05 mg/kg) and at high doses in combination with EDmix (5 mg/kg +EDmix and 25 mg/kg + EDmix). Slight effects on offspring learning and memory did not appear correlated to decreased TH levels during development.
Conclusions
PFHxS decreased circulating levels of T3 and T4 in pregnant rat dams and their offspring without apparent compensation by the HPT axis. The thyroid hormone disruption was not associated with detectable learning and memory deficits. Rather findings suggest that PFHxS may disrupt sexual differentiation of the brain. Standard behavioral assays appear insensitive to adverse effects on brain development caused by thyroid hormone disruption. Hence, there is a need for development of sensitive assays to protect human thyroid function. Does not reflect EPA policy.
Original languageEnglish
Publication date2018
Number of pages1
Publication statusPublished - 2018
Event88th Annual Meeting of the American Thyroid Association - Marriott Marquis, Washington, DC, United States
Duration: 3 Oct 20187 Oct 2018
Conference number: 88
https://www.thyroid.org/88th-annual-meeting-ata/

Conference

Conference88th Annual Meeting of the American Thyroid Association
Number88
LocationMarriott Marquis
CountryUnited States
CityWashington, DC
Period03/10/201807/10/2018
Internet address

Cite this

Ramhøj, L., Boberg, J., Wood, C., Gilbert, M., Vinggaard, A. M., & Petersen, M. A. (2018). PFHxS Causes Developmental Hypothyroxinemia Without Affecting Behavioral Tests in Rat Offspring. Abstract from 88th Annual Meeting of the American Thyroid Association, Washington, DC, United States.
Ramhøj, Louise ; Boberg, Julie ; Wood, C. ; Gilbert, M. ; Vinggaard, Anne Marie ; Petersen, Marta Axelstad. / PFHxS Causes Developmental Hypothyroxinemia Without Affecting Behavioral Tests in Rat Offspring. Abstract from 88th Annual Meeting of the American Thyroid Association, Washington, DC, United States.1 p.
@conference{f96851c7a7f647d186381105b7bfa670,
title = "PFHxS Causes Developmental Hypothyroxinemia Without Affecting Behavioral Tests in Rat Offspring",
abstract = "IntroductionThyroid hormones (TH) are critical for mammalian brain development. In humans, low maternal serum thyroxine (T4) levels are associated with neurological deficiencies and cognitive impairment. Perfluorohexane sulfonate (PFHxS) is a widespread environmental contaminant found in human serum, tissues and milk. We have shown that PFHxS decrease serum thyroxine in pregnant rat dams and their offspring. Here, we further investigate effects on the thyroid system, neurodevelopment, and combination effects of PFHxS and a mixture of environmentally relevant endocrine disruptors.MethodsPerfluorohexane sulfonate (PFHxS, 0, 0.05, 5 or 25 mg/kg/day with and without EDmix, a mixture of 12 endocrine disruptors e.g. phthalates, pesticides, UV-filters, Bisphenol A and butyl paraben) was administered (p.o.) to Wistar rat dams (n = 16-20/dose group) from gestation day (GD) 7 through postnatal day (PD) 22. Offspring were assessed in activity boxes and the radial arm maze.Results/discussionPFHxS not only decreased serum T4 levels in dams and offspring but in the high dose also reduced T3 to 84{\%} of controls in both dams (PD 22) and pups (PD 16). The hypothalamic-pituitary-thyroid (HPT) axis was not activated based on lack of effect on serum TSH, thyroid gland histology, weight and thyroid gene expression levels. Developmental hypothyroxinemia did not appear to increase physical activity levels in young and adult offspring. However, the expected sex difference was absent on PD 115 in low dose PFHxS (0.05 mg/kg) and at high doses in combination with EDmix (5 mg/kg +EDmix and 25 mg/kg + EDmix). Slight effects on offspring learning and memory did not appear correlated to decreased TH levels during development.ConclusionsPFHxS decreased circulating levels of T3 and T4 in pregnant rat dams and their offspring without apparent compensation by the HPT axis. The thyroid hormone disruption was not associated with detectable learning and memory deficits. Rather findings suggest that PFHxS may disrupt sexual differentiation of the brain. Standard behavioral assays appear insensitive to adverse effects on brain development caused by thyroid hormone disruption. Hence, there is a need for development of sensitive assays to protect human thyroid function. Does not reflect EPA policy.",
author = "Louise Ramh{\o}j and Julie Boberg and C. Wood and M. Gilbert and Vinggaard, {Anne Marie} and Petersen, {Marta Axelstad}",
year = "2018",
language = "English",
note = "88th Annual Meeting of the American Thyroid Association, ATA 2018 ; Conference date: 03-10-2018 Through 07-10-2018",
url = "https://www.thyroid.org/88th-annual-meeting-ata/",

}

Ramhøj, L, Boberg, J, Wood, C, Gilbert, M, Vinggaard, AM & Petersen, MA 2018, 'PFHxS Causes Developmental Hypothyroxinemia Without Affecting Behavioral Tests in Rat Offspring', 88th Annual Meeting of the American Thyroid Association, Washington, DC, United States, 03/10/2018 - 07/10/2018.

PFHxS Causes Developmental Hypothyroxinemia Without Affecting Behavioral Tests in Rat Offspring. / Ramhøj, Louise; Boberg, Julie; Wood, C.; Gilbert, M.; Vinggaard, Anne Marie; Petersen, Marta Axelstad.

2018. Abstract from 88th Annual Meeting of the American Thyroid Association, Washington, DC, United States.

Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

TY - ABST

T1 - PFHxS Causes Developmental Hypothyroxinemia Without Affecting Behavioral Tests in Rat Offspring

AU - Ramhøj, Louise

AU - Boberg, Julie

AU - Wood, C.

AU - Gilbert, M.

AU - Vinggaard, Anne Marie

AU - Petersen, Marta Axelstad

PY - 2018

Y1 - 2018

N2 - IntroductionThyroid hormones (TH) are critical for mammalian brain development. In humans, low maternal serum thyroxine (T4) levels are associated with neurological deficiencies and cognitive impairment. Perfluorohexane sulfonate (PFHxS) is a widespread environmental contaminant found in human serum, tissues and milk. We have shown that PFHxS decrease serum thyroxine in pregnant rat dams and their offspring. Here, we further investigate effects on the thyroid system, neurodevelopment, and combination effects of PFHxS and a mixture of environmentally relevant endocrine disruptors.MethodsPerfluorohexane sulfonate (PFHxS, 0, 0.05, 5 or 25 mg/kg/day with and without EDmix, a mixture of 12 endocrine disruptors e.g. phthalates, pesticides, UV-filters, Bisphenol A and butyl paraben) was administered (p.o.) to Wistar rat dams (n = 16-20/dose group) from gestation day (GD) 7 through postnatal day (PD) 22. Offspring were assessed in activity boxes and the radial arm maze.Results/discussionPFHxS not only decreased serum T4 levels in dams and offspring but in the high dose also reduced T3 to 84% of controls in both dams (PD 22) and pups (PD 16). The hypothalamic-pituitary-thyroid (HPT) axis was not activated based on lack of effect on serum TSH, thyroid gland histology, weight and thyroid gene expression levels. Developmental hypothyroxinemia did not appear to increase physical activity levels in young and adult offspring. However, the expected sex difference was absent on PD 115 in low dose PFHxS (0.05 mg/kg) and at high doses in combination with EDmix (5 mg/kg +EDmix and 25 mg/kg + EDmix). Slight effects on offspring learning and memory did not appear correlated to decreased TH levels during development.ConclusionsPFHxS decreased circulating levels of T3 and T4 in pregnant rat dams and their offspring without apparent compensation by the HPT axis. The thyroid hormone disruption was not associated with detectable learning and memory deficits. Rather findings suggest that PFHxS may disrupt sexual differentiation of the brain. Standard behavioral assays appear insensitive to adverse effects on brain development caused by thyroid hormone disruption. Hence, there is a need for development of sensitive assays to protect human thyroid function. Does not reflect EPA policy.

AB - IntroductionThyroid hormones (TH) are critical for mammalian brain development. In humans, low maternal serum thyroxine (T4) levels are associated with neurological deficiencies and cognitive impairment. Perfluorohexane sulfonate (PFHxS) is a widespread environmental contaminant found in human serum, tissues and milk. We have shown that PFHxS decrease serum thyroxine in pregnant rat dams and their offspring. Here, we further investigate effects on the thyroid system, neurodevelopment, and combination effects of PFHxS and a mixture of environmentally relevant endocrine disruptors.MethodsPerfluorohexane sulfonate (PFHxS, 0, 0.05, 5 or 25 mg/kg/day with and without EDmix, a mixture of 12 endocrine disruptors e.g. phthalates, pesticides, UV-filters, Bisphenol A and butyl paraben) was administered (p.o.) to Wistar rat dams (n = 16-20/dose group) from gestation day (GD) 7 through postnatal day (PD) 22. Offspring were assessed in activity boxes and the radial arm maze.Results/discussionPFHxS not only decreased serum T4 levels in dams and offspring but in the high dose also reduced T3 to 84% of controls in both dams (PD 22) and pups (PD 16). The hypothalamic-pituitary-thyroid (HPT) axis was not activated based on lack of effect on serum TSH, thyroid gland histology, weight and thyroid gene expression levels. Developmental hypothyroxinemia did not appear to increase physical activity levels in young and adult offspring. However, the expected sex difference was absent on PD 115 in low dose PFHxS (0.05 mg/kg) and at high doses in combination with EDmix (5 mg/kg +EDmix and 25 mg/kg + EDmix). Slight effects on offspring learning and memory did not appear correlated to decreased TH levels during development.ConclusionsPFHxS decreased circulating levels of T3 and T4 in pregnant rat dams and their offspring without apparent compensation by the HPT axis. The thyroid hormone disruption was not associated with detectable learning and memory deficits. Rather findings suggest that PFHxS may disrupt sexual differentiation of the brain. Standard behavioral assays appear insensitive to adverse effects on brain development caused by thyroid hormone disruption. Hence, there is a need for development of sensitive assays to protect human thyroid function. Does not reflect EPA policy.

M3 - Conference abstract for conference

ER -

Ramhøj L, Boberg J, Wood C, Gilbert M, Vinggaard AM, Petersen MA. PFHxS Causes Developmental Hypothyroxinemia Without Affecting Behavioral Tests in Rat Offspring. 2018. Abstract from 88th Annual Meeting of the American Thyroid Association, Washington, DC, United States.